Gen Bio AI (IDO) is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
General-purpose cell simulator predicts multimodal biological outcomes, reducing wet-lab experiments 1000x; enables in silico drug screening and personalized digital twins, representing 'the end of medicine' and path to longevity escape velocity.